Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rocket Pharmaceuticals (RCKT) Return on Capital Employed: 2017-2025

Historic Return on Capital Employed for Rocket Pharmaceuticals (RCKT) over the last 9 years, with Sep 2025 value amounting to -0.69%.

  • Rocket Pharmaceuticals' Return on Capital Employed rose 3.00% to -0.69% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.69%, marking a year-over-year increase of 3.00%. This contributed to the annual value of -0.54% for FY2024, which is 3.00% down from last year.
  • Rocket Pharmaceuticals' Return on Capital Employed amounted to -0.69% in Q3 2025, which was down 3.70% from -0.66% recorded in Q2 2025.
  • Rocket Pharmaceuticals' 5-year Return on Capital Employed high stood at -0.28% for Q1 2021, and its period low was -0.72% during Q3 2024.
  • In the last 3 years, Rocket Pharmaceuticals' Return on Capital Employed had a median value of -0.58% in 2025 and averaged -0.59%.
  • As far as peak fluctuations go, Rocket Pharmaceuticals' Return on Capital Employed dropped by 19bps in 2024, and later increased by 3bps in 2025.
  • Quarterly analysis of 5 years shows Rocket Pharmaceuticals' Return on Capital Employed stood at -0.34% in 2021, then fell by 16bps to -0.50% in 2022, then rose by 2bps to -0.49% in 2023, then decreased by 16bps to -0.65% in 2024, then increased by 3bps to -0.69% in 2025.
  • Its Return on Capital Employed was -0.69% in Q3 2025, compared to -0.66% in Q2 2025 and -0.58% in Q1 2025.